• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年患者的脓毒症与免疫衰老:综述

Sepsis and Immunosenescence in the Elderly Patient: A Review.

作者信息

Martín Silvia, Pérez Alba, Aldecoa Cesar

机构信息

Anaesthesia and Surgical Critical Care, Hospital Universitario rio Hortega , Valladolid , Spain.

Anaesthesia and Surgical Critical Care, Hospital Universitario rio Hortega, Valladolid, Spain; University of Valladolid Medical School, Valladolid, Spain.

出版信息

Front Med (Lausanne). 2017 Feb 28;4:20. doi: 10.3389/fmed.2017.00020. eCollection 2017.

DOI:10.3389/fmed.2017.00020
PMID:28293557
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5329014/
Abstract

Sepsis is a prevalent, serious medical condition with substantial mortality and a significant consumption of health-care resources. Its incidence has increased around 9% annually in general population over the last years and specially in aged patients group. Several risk factors such as comorbidities, preadmission status, malnutrition, frailty, and an impared function in the immune system called immunosenescence are involved in the higher predisposition to sepsis in the elderly patients. Immunosenescence status consists in a functional impairment in both cell-mediated immunity and humoral immune responses and increases not only the risk for develop sepsis but also lead to more severe presentation of infection and may be is also related with a higher mortality. There is a also a concern about to admit patients in the intensive care units taking into account that the outcome of elderly patients is poorer compared to younger people. Nevertheless, the management of septic elderly patients does not differ substantially from younger people. In addition, the quality of life in septic elderly survivors is also lower than in younger people. But age, as alone factor, should not be used to determine treatment options because the poorer outcomes is thought to be due to the increased comorbidities and frailty in this group of patients.

摘要

脓毒症是一种常见且严重的疾病,死亡率高,消耗大量医疗资源。在过去几年中,普通人群中其发病率每年约增加9%,老年患者群体中尤为如此。多种风险因素,如合并症、入院前状态、营养不良、虚弱以及免疫系统功能受损(称为免疫衰老),使得老年患者更易患脓毒症。免疫衰老表现为细胞介导免疫和体液免疫反应的功能障碍,不仅增加了发生脓毒症的风险,还导致感染表现更为严重,可能还与更高的死亡率相关。考虑到老年患者在重症监护病房的预后比年轻人差,是否收治老年患者也令人担忧。然而,脓毒症老年患者的治疗与年轻人并无显著差异。此外,脓毒症老年幸存者的生活质量也低于年轻人。但年龄本身不应作为决定治疗方案的因素,因为该群体较差的预后被认为是由于合并症增加和身体虚弱所致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c421/5329014/5ec4bf832bd2/fmed-04-00020-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c421/5329014/f80d823dfea9/fmed-04-00020-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c421/5329014/5ec4bf832bd2/fmed-04-00020-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c421/5329014/f80d823dfea9/fmed-04-00020-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c421/5329014/5ec4bf832bd2/fmed-04-00020-g002.jpg

相似文献

1
Sepsis and Immunosenescence in the Elderly Patient: A Review.老年患者的脓毒症与免疫衰老:综述
Front Med (Lausanne). 2017 Feb 28;4:20. doi: 10.3389/fmed.2017.00020. eCollection 2017.
2
Severe sepsis and its impact on outcome in elderly and very elderly patients admitted in intensive care unit.严重脓毒症及其对入住重症监护病房的老年和非常老年患者预后的影响。
J Intensive Care Med. 2012 May-Jun;27(3):179-83. doi: 10.1177/0885066610397116. Epub 2011 Mar 24.
3
Sepsis Care Pathway 2019.2019年脓毒症护理路径
Qatar Med J. 2019 Nov 7;2019(2):4. doi: 10.5339/qmj.2019.qccc.4. eCollection 2019.
4
[Immunosenescence: a review].[免疫衰老:综述]
Geriatr Psychol Neuropsychiatr Vieil. 2015 Sep;13 Suppl 2:7-14. doi: 10.1684/pnv.2015.0548.
5
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).阿片类药物与老年人慢性重度疼痛的管理:一个国际专家小组的共识声明,重点关注世界卫生组织第三阶梯临床最常用的六种阿片类药物(丁丙诺啡、芬太尼、氢吗啡酮、美沙酮、吗啡、羟考酮)。
Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.
6
The effect of age on the development and outcome of adult sepsis.年龄对成人脓毒症发生发展及预后的影响。
Crit Care Med. 2006 Jan;34(1):15-21. doi: 10.1097/01.ccm.0000194535.82812.ba.
7
Comparative analysis of survival between elderly and non-elderly severe sepsis and septic shock resuscitated patients.老年与非老年严重脓毒症及脓毒性休克复苏患者生存情况的对比分析
Einstein (Sao Paulo). 2015 Jul-Sep;13(3):357-63. doi: 10.1590/S1679-45082015AO3313. Epub 2015 Aug 21.
8
[Sepsis : particularities in the elderly patients].[脓毒症:老年患者的特殊性]
Rev Med Suisse. 2016 Nov 9;12(538):1917-1921.
9
T-Cell Phenotypes Predictive of Frailty and Mortality in Elderly Nursing Home Residents.T 细胞表型可预测老年疗养院居民的虚弱和死亡。
J Am Geriatr Soc. 2017 Jan;65(1):153-159. doi: 10.1111/jgs.14507. Epub 2016 Oct 24.
10
[Clinical characteristics and prognosis of acute kidney injury in elderly patients with sepsis].[老年脓毒症患者急性肾损伤的临床特征与预后]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 Jul;31(7):837-841. doi: 10.3760/cma.j.issn.2095-4352.2019.07.008.

引用本文的文献

1
Klotho: A multifaceted protector in sepsis-induced organ damage and a potential therapeutic target.α-klotho:脓毒症诱导器官损伤中的多面保护因子及潜在治疗靶点
World J Crit Care Med. 2025 Sep 9;14(3):103458. doi: 10.5492/wjccm.v14.i3.103458.
2
Bug Wars: Artificial Intelligence Strikes Back in Sepsis Management.细菌大战:人工智能在脓毒症管理中卷土重来
Diagnostics (Basel). 2025 Jul 28;15(15):1890. doi: 10.3390/diagnostics15151890.
3
Lower Initial Insulin-like Growth Factor-Binding Protein-3 Concentrations May Reflect Immune Suppression and Predict Increased Risk of Sepsis-Related Mortality.

本文引用的文献

1
Phylogenetic analysis of the human antibody repertoire reveals quantitative signatures of immune senescence and aging.人类抗体库的系统发育分析揭示了免疫衰老和老化的定量特征。
Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):1105-1110. doi: 10.1073/pnas.1617959114. Epub 2017 Jan 17.
2
Towards precision medicine for sepsis patients.迈向脓毒症患者的精准医学
Crit Care. 2017 Jan 12;21(1):11. doi: 10.1186/s13054-016-1583-z.
3
Effectiveness of High Cut-Off Hemofilters in the Removal of Selected Cytokines in Patients During Septic Shock Accompanied by Acute Kidney Injury-Preliminary Study.
较低的初始胰岛素样生长因子结合蛋白-3浓度可能反映免疫抑制,并预示脓毒症相关死亡率增加的风险。
Int J Mol Sci. 2025 Jul 8;26(14):6549. doi: 10.3390/ijms26146549.
4
Evaluation of Infections Caused by Carbapenem-Resistant , , and in an Intensive Care Unit: A Retrospective Study.重症监护病房中耐碳青霉烯类[细菌名称缺失]和[细菌名称缺失]引起的感染评估:一项回顾性研究
Antibiotics (Basel). 2025 Jul 12;14(7):700. doi: 10.3390/antibiotics14070700.
5
Early Prediction of In-Hospital Mortality in Patients with Acute Infections: Development of the Acute Severity Infection Score (ASIs).急性感染患者院内死亡的早期预测:急性严重感染评分(ASIs)的开发
Infect Dis Ther. 2025 Sep;14(9):2053-2070. doi: 10.1007/s40121-025-01200-8. Epub 2025 Jul 26.
6
Innate immunosenescence and sepsis in the elderly: mechanisms and innate immune modulation strategies.老年人的先天性免疫衰老与脓毒症:机制及先天性免疫调节策略
Cent Eur J Immunol. 2025;50(1):3-10. doi: 10.5114/ceji.2025.149291. Epub 2025 May 5.
7
Enhancing sepsis management: the role of dynamic heparin-binding protein monitoring in elderly patients.加强脓毒症管理:动态肝素结合蛋白监测在老年患者中的作用
Front Med (Lausanne). 2025 Jun 11;12:1538515. doi: 10.3389/fmed.2025.1538515. eCollection 2025.
8
Upper gastrointestinal bleeding differences between older and younger adults: should bleeding in non-cirrhotic patients be considered a geriatric syndrome?老年人与年轻人上消化道出血的差异:非肝硬化患者的出血是否应被视为一种老年综合征?
Therap Adv Gastroenterol. 2025 Jun 9;18:17562848251343416. doi: 10.1177/17562848251343416. eCollection 2025.
9
Identifying Risk Factors for Myocardial Injury in Elderly Patients with Sepsis.识别老年脓毒症患者心肌损伤的危险因素。
Med Sci Monit. 2025 May 18;31:e947840. doi: 10.12659/MSM.947840.
10
Unraveling immunosenescence in sepsis: from cellular mechanisms to therapeutics.解析脓毒症中的免疫衰老:从细胞机制到治疗方法
Cell Death Dis. 2025 May 16;16(1):393. doi: 10.1038/s41419-025-07714-w.
高截留量血液滤过器对伴有急性肾损伤的感染性休克患者特定细胞因子的清除效果——初步研究
Med Sci Monit. 2016 Nov 13;22:4338-4344. doi: 10.12659/MSM.896819.
4
Levosimendan for the Prevention of Acute Organ Dysfunction in Sepsis.左西孟旦用于预防脓毒症急性器官功能障碍
N Engl J Med. 2016 Oct 27;375(17):1638-1648. doi: 10.1056/NEJMoa1609409. Epub 2016 Oct 5.
5
Long-Term Outcomes After ICU Admission Triage in Octogenarians.八旬老人入住重症监护病房后的长期预后
Crit Care Med. 2017 Apr;45(4):e363-e371. doi: 10.1097/CCM.0000000000002098.
6
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).《脓毒症及脓毒性休克第三次国际共识定义(脓毒症-3)》
JAMA. 2016 Feb 23;315(8):801-10. doi: 10.1001/jama.2016.0287.
7
Defining immunological dysfunction in sepsis: A requisite tool for precision medicine.定义脓毒症中的免疫功能障碍:精准医学的必要工具。
J Infect. 2016 May;72(5):525-36. doi: 10.1016/j.jinf.2016.01.010. Epub 2016 Feb 3.
8
Sepsis-induced immune dysfunction: can immune therapies reduce mortality?脓毒症诱导的免疫功能障碍:免疫疗法能否降低死亡率?
J Clin Invest. 2016 Jan;126(1):23-31. doi: 10.1172/JCI82224. Epub 2016 Jan 4.
9
Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial.白细胞介素-1受体阻断与具有巨噬细胞活化综合征特征的脓毒症患者死亡率降低相关:对一项既往III期试验的重新分析
Crit Care Med. 2016 Feb;44(2):275-81. doi: 10.1097/CCM.0000000000001402.
10
IMMUNE CELL PHENOTYPE AND FUNCTION IN SEPSIS.脓毒症中的免疫细胞表型与功能
Shock. 2016 Mar;45(3):282-91. doi: 10.1097/SHK.0000000000000495.